サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676100

持続的腎代替療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Continuous Renal Replacement Therapy Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 160 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
持続的腎代替療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 160 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

持続的腎代替療法の世界市場規模は、2024年の21億6,000万米ドルから2033年には43億6,000万米ドルに成長し、2026～2033年の予測期間中に8.07％の堅調な年間平均成長率（CAGR）を示すと予測されます。

持続的腎代替療法（CRRT）市場は、急性腎障害（AKI）と慢性腎臓病（CKD）の有病率が世界的に上昇し続けていることから、大きな成長が見込まれています。CRRTは、重度の腎機能障害を持つ患者にとって不可欠な治療手段であり、体液と電解質のバランスを維持するために継続的で穏やかな透析を行います。腎臓病の主要危険因子である糖尿病や高血圧などの疾患の発生率が増加していることが、CRRTソリューションの需要を促進しています。さらに、高齢化人口の増加と腎臓支援を必要とする重症患者の増加が、市場拡大をさらに後押ししています。

技術の進歩は、CRRT市場の将来を形作る上で重要な役割を果たしています。濾過技術の向上やユーザーフレンドリーなインターフェースなど、透析装置の技術革新がCRRT治療の効率と効果を高めています。さらに、遠隔モニタリングや遠隔医療ソリューションの統合により、医療プロバイダーはCRRT療法をより効果的に管理できるようになり、患者の予後が向上しています。メーカーが研究開発への投資を続けているため、CRRT市場は、病院や外来クリニックなど、さまざまな医療環境での採用が増加すると考えられます。

さらに、患者中心の医療と個別化医療が重視されるようになっていることも、CRRT市場に影響を与えています。医療プロバイダーが個々の患者のニーズに合わせて治療を行おうとする中、カスタマイズ可能な設定や治療プロトコルを提供するCRRTシステムに対する需要が高まっています。この動向は、患者固有の要件に適応できる先進的CRRTソリューションの開発を促進し、全体的な治療効果を向上させています。市場が進化を続ける中、技術の統合、個別化、患者の関与が成功の重要な促進要因となると考えられます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をクライアントに提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 持続的腎代替療法産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 持続的腎代替療法の世界市場分析：モード別

  • モード別概要
  • モード別過去・予測データ分析
  • 緩徐連続限外濾過（SCUF）
  • 持続的静脈血液濾過（CVVHF）
  • 持続的静脈血液透析（CVVHD）
  • 持続的静脈血液濾過透析（CVVHDF）

第6章 持続的腎代替療法の世界市場分析：製品別

  • 製品別概要
  • 製品別過去・予測データ分析
  • 透析液と交換液
  • ディスポーザブル
  • システム

第7章 持続的腎代替療法の世界市場分析：療法別

  • 療法別概要
  • 療法別過去・予測データ分析
  • 腎臓
  • 非腎
  • 併用療法

第8章 持続的腎代替療法の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 病院
  • クリニック
  • その他

第9章 持続的腎代替療法の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 持続的腎代替療法企業の競合情勢

  • 持続的腎代替療法市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Asahi Kasei Corporation
  • Medtronic
  • DaVita Inc.
  • NxStage Medical Inc.
  • Toray Medical Company Limited
  • Astellas Pharma Inc.
  • CytoSorbents Corp.
  • Infomed SA
  • Medica SPA
  • Medical Components Inc.
  • Medites Pharma Spol. S.R.O
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Mode (USD MN)
  • Slow Continuous Ultrafiltration (SCUF) Market Sales By Geography (USD MN)
  • Continuous Venovenous Hemofiltration (CVVHF) Market Sales By Geography (USD MN)
  • Continuous Venovenous Haemodialysis (CVVHD) Market Sales By Geography (USD MN)
  • Continuous Venovenous Hemodiafiltration (CVVHDF) Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Dialysates And Replacement Fluids Market Sales By Geography (USD MN)
  • Disposables Market Sales By Geography (USD MN)
  • Systems Market Sales By Geography (USD MN)
  • Analysis By Therapy (USD MN)
  • Renal Market Sales By Geography (USD MN)
  • Non-renal Market Sales By Geography (USD MN)
  • Combination Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Continuous Renal Replacement Therapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Continuous Renal Replacement Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Continuous Renal Replacement Therapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Mode
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Therapy
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Mode (USD MN)
  • Slow Continuous Ultrafiltration (SCUF) Market Sales By Geography (USD MN)
  • Continuous Venovenous Hemofiltration (CVVHF) Market Sales By Geography (USD MN)
  • Continuous Venovenous Haemodialysis (CVVHD) Market Sales By Geography (USD MN)
  • Continuous Venovenous Hemodiafiltration (CVVHDF) Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Dialysates And Replacement Fluids Market Sales By Geography (USD MN)
  • Disposables Market Sales By Geography (USD MN)
  • Systems Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapy (USD MN)
  • Renal Market Sales By Geography (USD MN)
  • Non-renal Market Sales By Geography (USD MN)
  • Combination Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11218337

Global Continuous Renal Replacement Therapy Market size is anticipated to grow from USD 2.16 Billion in 2024 to USD 4.36 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.07% during the forecast period of 2026 to 2033.

The Continuous Renal Replacement Therapy (CRRT) Market is poised for significant growth as the prevalence of acute kidney injury (AKI) and chronic kidney disease (CKD) continues to rise globally. CRRT is a vital treatment modality for patients with severe renal impairment, providing continuous and gentle dialysis to maintain fluid and electrolyte balance. The increasing incidence of conditions such as diabetes and hypertension, which are major risk factors for kidney disease, is driving demand for CRRT solutions. Additionally, the growing aging population and the rising number of critically ill patients requiring renal support are further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the CRRT market. Innovations in dialysis machines, including improved filtration technologies and user-friendly interfaces, are enhancing the efficiency and effectiveness of CRRT treatments. Furthermore, the integration of remote monitoring and telehealth solutions is enabling healthcare providers to manage CRRT therapies more effectively, ensuring better patient outcomes. As manufacturers continue to invest in research and development, the CRRT market is likely to see increased adoption across various healthcare settings, including hospitals and outpatient clinics.

Moreover, the growing emphasis on patient-centered care and personalized medicine is influencing the CRRT market. As healthcare providers seek to tailor treatments to individual patient needs, there is a rising demand for CRRT systems that offer customizable settings and treatment protocols. This trend is driving the development of advanced CRRT solutions that can adapt to the specific requirements of patients, improving overall treatment efficacy. As the market continues to evolve, the integration of technology, personalization, and patient engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Mode

  • Slow Continuous Ultrafiltration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVHF)
  • Continuous Venovenous Haemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

By Product

  • Dialysates And Replacement Fluids
  • Disposables
  • Systems

By Therapy

  • Renal
  • Non-renal
  • Combination

By End User

  • Hospitals
  • Clinics
  • Others
  • COMPANIES PROFILED
  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Asahi Kasei Corporation
  • Medtronic
  • DaVita Inc.
  • NxStage Medical Inc.
  • Toray Medical Company Limited
  • Astellas Pharma Inc.
  • CytoSorbents Corp.
  • Infomed SA
  • Medica SPA
  • Medical Components Inc.
  • Medites Pharma spol. s.r.o.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CONTINUOUS RENAL REPLACEMENT THERAPY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Mode
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Therapy
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY MODE

  • 5.1. Overview By Mode
  • 5.2. Historical and Forecast Data Analysis By Mode
  • 5.3. Slow Continuous Ultrafiltration (SCUF) Historic and Forecast Sales By Regions
  • 5.4. Continuous Venovenous Hemofiltration (CVVHF) Historic and Forecast Sales By Regions
  • 5.5. Continuous Venovenous Haemodialysis (CVVHD) Historic and Forecast Sales By Regions
  • 5.6. Continuous Venovenous Hemodiafiltration (CVVHDF) Historic and Forecast Sales By Regions

6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Dialysates And Replacement Fluids Historic and Forecast Sales By Regions
  • 6.4. Disposables Historic and Forecast Sales By Regions
  • 6.5. Systems Historic and Forecast Sales By Regions

7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY THERAPY

  • 7.1. Overview By Therapy
  • 7.2. Historical and Forecast Data Analysis By Therapy
  • 7.3. Renal Historic and Forecast Sales By Regions
  • 7.4. Non-renal Historic and Forecast Sales By Regions
  • 7.5. Combination Historic and Forecast Sales By Regions

8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Clinics Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CONTINUOUS RENAL REPLACEMENT THERAPY COMPANIES

  • 10.1. Continuous Renal Replacement Therapy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF CONTINUOUS RENAL REPLACEMENT THERAPY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Fresenius Medical Care AG & Co. KGaA
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Baxter International Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. B. Braun Melsungen AG
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Nipro Corporation
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Asahi Kasei Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Medtronic
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. DaVita Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. NxStage Medical Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Toray Medical Company Limited
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Astellas Pharma Inc.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. CytoSorbents Corp.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Infomed SA
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Medica SPA
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Medical Components Inc.
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Medites Pharma Spol. S.R.O
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies